Data Coordinator
Sarah Cannon Research Institute
Summary
The Data Coordinator provides support to Study Coordinators on a daily basis; ensures all activities are conducted according to company standard operating procedures (SOPs) and all applicable Good Clinical Practice (GCP) and ICH regulations and guidelines.
Job description
- Support Study Coordinators to meet industry trial data deadlines
- Obtain source documentation for patients enrolled into clinical trial
- Assist Study Coordinators with case report form completion and query resolution
- Assist in Serious Adverse Event (SAE) reporting and tracking
- Create and maintain patient visit tracking spreadsheets for Study Coordinators
- Maintain and archive study administrative files
- Be assigned special procedural projects to enhance the functioning of Drug Development Data Operations
- Assess adherence to SCRI SOPs, Good Clinical Practice (GCP) and ICH regulations and guidelines throughout the conduct of the clinical trial
Requirements
- Knowledge of scientific, medical, and regulatory terms
- Knowledge of GCP and Good Manufacturing Practice (GMP)
- Detail-oriented
- Excellent English written and oral skills
- Bachelor's degree preferred
- Healthcare experience, clinical trials support, or pharmaceutical industry experience preferred
Benefits
- Comprehensive benefits
- Physical well-being support
- Mental well-being support
- Financial well-being support
- Competitive compensation package
Company overview
Sarah Cannon Research Institute (SCRI) is a premier oncology research organization and global leader in community-based clinical trials. Founded in 2004 through a joint venture between Tennessee Oncology and Hospital Corporation of America, SCRI has established itself as one of the world's leading cancer research institutions. With headquarters in Nashville, Tennessee, the institute operates across more than 200 locations in over 20 U.S. states and the United Kingdom, bringing together more than 1,300 research physicians. SCRI specializes in conducting first-in-human clinical trials, having completed over 850 such studies since its inception, and has contributed significantly to the development of approximately 10 FDA-approved cancer therapies since 1999. The organization focuses primarily on oncology research while also expanding into cardiology, gastroenterology, and other therapeutic areas. SCRI's unique community-based model enables patients to access cutting-edge clinical trials close to home, bridging the gap between academic research centers and local healthcare providers. The institute employs 501-1,000 professionals and maintains strategic partnerships with pharmaceutical and biotechnology companies to advance cancer treatment innovations.